Table 1. Correlation between PROX1 or α-SMA expression and patients’ clinicopathological characteristics.

Clinical characteristics	PROX1 expression		P-value	α-SMA expression		P-value
	High (n = 116)	Low (n = 48)		High (n = 130)	Low (n = 34)
Gender			0.70			0.60
Male	57	22		64	15
Female	59	26		66	19
Mean age	66.0	62.9	0.16	65.4	63.9	0.079
Location			0.29			0.70
Right side	44	14		45	13
Left side	72	34		85	21
Size			<0.001			<0.001
≤5 cm	44	41		55	30
>5 cm	72	7		75	4
Histology type			<0.001			<0.001
Well	0	10		0	10
Moderate	100	35		114	21
High or mucinous	16	3		16	3
Serosal invasion			<0.001			<0.001
Positive	111	20		123	8
Negative	5	28		7	26
Lymphatic invasion			0.002			0.004
Positive	65	14		70	9
Negative	51	34		60	25
Venous invasion			0.089			0.11
Positive	53	15		58	10
Negative	63	33		62	24
Lymph node metastasis			<0.001			<0.001
Positive	69	9		76	2
Negative	47	39		54	32
Distant metastasis			0.016			0.055
Positive	13	0		13	0
Negative	103	48		117	34
Stage
I	0	27	<0.001	2	25	<0.001
II	45	12		50	7
III	58	9		65	2
IV	13	0		13	0